John Murphy, CEO The COVID-19 Long-haul Foundation Introduction The emergence of SARS-CoV-2 in late 2019 marked the beginning of a global health crisis that has since reshaped the landscape of […]
Neurovestibular Sequelae of Long COVID: A Multisystem Analysis of Vertigo, Genomic Resonance, and Clinical Consequence
Author: John Murphy, MD CEO & President, COVID-19 Long-haul Foundation Abstract Vertigo and disequilibrium are increasingly recognized as disabling sequelae of Long COVID, yet remain under-characterized in clinical literature. This […]
COVID-19-Related Spontaneous Vertebral Artery Dissection: A Case Report
Thamer AlAifan • Aisha Halawani • Nora Shalabi •et. al., DOI: 10.7759/cureus.84265 Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with various vascular complications, including arterial dissections. This […]
Early COVID-19 Vaccine Patent In China Raises New Questions For U.S. Investigators
A Chinese patent for a COVID-19 vaccine filed just weeks after the virus emerged in the United States is drawing fresh scrutiny from U.S. investigators examining the origins of the pandemic […]
Incidence of Neurological Manifestations in Critically Ill COVID-19 Patients
Sasa Dragic • Andrea Dolencuk • Danica Momcicevic • et. al., DOI: 10.7759/cureus.85616 Abstract Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not primarily a neurotropic virus. However, since angiotensin-converting enzyme 2 (ACE2) receptors are present […]
Pathophysiological, immunological, and inflammatory features of long COVID
Karen Bohmwald1,2†Benjamín Diethelm-Varela1†Linmar Rodríguez-Guilarte1 , et. al., Front. Immunol., 27 February 2024, Sec. Viral Immunology, Volume 15 – 2024 | https://doi.org/10.3389/fimmu.2024.1341600 The COVID-19 pandemic continues to cause severe global disruption, resulting […]